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a  b  s  t  r  a  c  t
Butafenacil  is an  herbicide  that  inhibits  protoporphyrinogen  oxidase  (PPOX),  an enzyme  that  catalyzes
oxidation  of  protoporphyrinogen  IX to protoporphyrin  IX  during  chlorophyll  and  heme biosynthesis.
Based  on  a high-content  screen,  we previously  identiﬁed  butafenacil  as a potent  inducer  of anemia  in
zebraﬁsh  embryos.  Therefore,  the  objective  of this  study was  to begin  investigating  the  utility  of  butafe-
nacil  as  a positive  control  for identifying  anemia-  and  variegate  porphyria-inducing  chemicals.  Static
exposure  to butafenacil  from  5  to 72 h  post-fertilization  (hpf)  in  glass  beakers  resulted  in a  concentration-
dependent  decrease  in  arterial  circulation  at  low  micromolar  concentrations.  At  72  hpf,  the  magnitude
of  butafenacil-induced  anemia  was  similar  when  embryos  were  exposed  in  the  presence  or absence  of
light,  whereas  protoporphyrin  accumulation  and  acute  toxicity  were  signiﬁcantly  lower  or absent  when
embryos  were  exposed  under  dark  conditions.  To  identify  sensitive  developmental  windows,  we  treated
embryos  to butafenacil  from  5, 10,  24, or 48  hpf  to  72  hpf  in  the  presence  of  light,  and found  that  ane-
mia  and protoporphyrin  accumulation  were  present  at 72 hpf  following  initiation  of  exposure  at  5  and
10 hpf.  On  the contrary,  protoporphyrin  accumulation  – but  not  anemia  –  was  present  following  ini-
tiation  of  exposure  at 24  hpf. Lastly,  protoporphyrin  accumulation  at 72  hpf  after exposure  from  24 to
48  hpf  suggests  that protoporphyrin  was  not  eliminated  over  a 24-h  recovery  period.  Collectively,  our
data suggests  that  butafenacil  may  be a reliable  positive  control  for  identifying  anemia-  and  variegate
porphyria-inducing  chemicals.
©  2015  The  Authors.  Published  by Elsevier  Ireland  Ltd.  This  is an  open  access  article  under  the CC. Introduction
Butafenacil is a broad-spectrum imide herbicide that inhibits
rotoporphyrinogen oxidase (PPOX), an enzyme that catalyzes oxi-
ation of protoporphyrinogen IX to protoporphyrin IX – the last
ommon step of chlorophyll and heme biosynthesis in plants and
nimals, respectively. Similar to other post-emergent herbicides,
utafenacil is phytotoxic on contact and provides rapid knock-
own of broadleaf and grass weeds [14]. Butafenacil has been
egistered for agricultural use within Australia, Argentina, Brazil,
apan, Switzerland, and Thailand since the early 2000s, and, within
hese countries, is sold as a pre-mixed formulation containing other
ost-emergent herbicides such as triasulfuron and glyphosate [14].
Abbreviations: ai, active ingredient; DMSO, dimethyl sulfoxide; EM,  embryo
edia; hpf, hours post-fertilization; MS-222, tricaine methanesulfonate; PPOX, pro-
oporphyrinogen oxidase; RO, reverse osmosis.
∗ Corresponding author at: University of South Carolina, Department of Envi-
onmental Health Sciences, 921 Assembly St Public Health Research Center 401,
olumbia, SC 29208, USA. Fax: +1 803 777 3391.
E-mail address: volz@mailbox.sc.edu (D.C. Volz).
ttp://dx.doi.org/10.1016/j.toxrep.2015.07.006
214-7500/© 2015 The Authors. Published by Elsevier Ireland Ltd. This is an open access
c-nd/4.0/).BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).
As butafenacil targets PPOX in both plants and animals, expo-
sure of rodents (rats and mice) and aquatic plants (algae, diatoms,
and duckweed) to butafenacil results in hematologic abnormalities
and inhibition of growth, respectively, at relatively low concentra-
tions [14]. However, due to low application rates (one application
of <50 g ai/ha per year), rapid environmental degradation (t1/2 < 5
days), and little to no potential for bioaccumulation (t1/2 < 3 days),
butafenacil is not expected to pose a signiﬁcant human health nor
ecological risk following agricultural use according to the label
[14]. Based on a high-content screen using zebraﬁsh embryos, we
previously revealed that exposure to butafenacil from 5 to 72 h
post-fertilization (hpf) abolished blood cell and hemoglobin pro-
duction in the absence of effects on survival, body length, cardiac
function, and blood vessel development [13]. Therefore, based on
this study, we  identiﬁed butafenacil as a potential positive con-
trol for identifying chemicals that induce blood disorders such as
anemia and variegate porphyria.Anemia is an inherited or acquired disorder that is character-
ized by (1) abnormally low levels of circulating red blood cells due
to decreased red blood cell production, blood loss, or hemolysis
or (2) normal levels of circulating red blood cells that are micro-
 article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
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ytic and/or hypochromic. As a result of decreased oxygen delivery
hroughout the body, patients with anemia experience a variety
f symptoms (the most common being fatigue) and, in severe and
hronic cases, irreversible damage to vital organs [7]. Within the
nited States, anemia is the most prevalent blood disorder across
ll age, racial, and ethnic groups. Iron-deﬁciency anemia is the most
ommon form of anemia within American children, where preva-
ence is as high as 14% within children between 1 and 2 years
f age (http://www.cdc.gov/nchs/fastats/anemia.htm). Anemia can
lso be caused by chronic exposure to certain drugs used to treat
ancer and rheumatoid arthritis [11].
Porphyrias are a rare class of disorders caused by abnormal
eme production, leading to accumulation of porphyrins or por-
hyrin precursors within the liver and other organs [17]. Within the
nited States, less than 200,000 people are diagnosed with acute
r cutaneous porphyria, with the most prevalent form (porphyria
utanea tarda) resulting from chemically-induced deﬁciencies in
roporphyrinogen decarboxylase [1]. Variegate porphyria is a hep-
tic porphyria caused by a human PPOX mutation that decreases
xidation and conversion of protoporphyrinogen IX to proto-
orphyrin IX [2]. During acute attacks, patients with variegate
orphyria can experience abnormal skin reactions to sunlight (or
hotodermatitis) due to reactive singlet oxygen formation and
xidative stress following photooxidation of protoporphyrinogen
o protoporphyrin [2]. Moreover, certain drugs (e.g., barbiturates)
nd antibiotics (e.g., sulfonamides) can trigger acute symptoms of
orhyrias such as photodermatitis, underscoring the importance
f screening for potential effects on heme production during drug
evelopment.
As the identiﬁcation of potential adverse hematologic effects is
n important consideration during drug development, the objective
f this study was to begin investigating the utility of butafe-
acil as a positive control for identifying anemia- and variegate
orphyria-inducing chemicals. Our working hypothesis was  that,
imilar to variegate porphyria, butafenacil-mediated inhibition of
POX in transparent zebraﬁsh embryos results in accumulation of
rotoporphyrin and increased acute toxicity when reared under
ight conditions. To accomplish the overall objective of this study,
e conducted experiments to [1] determine whether butafenacil-
nduced anemia and variegate porphyria-like conditions occurs
n the presence or absence of light; [2] identify developmental
tages susceptible to butafenacil exposure within the ﬁrst 72 h of
mbryogenesis; and [3] determine whether butafenacil-induced
nemia and variegate porphyria-like conditions are reversible fol-
owing recovery within clean water until 72 hpf. In addition to
uantifying potential effects on survival, body area, arterial circu-
ation, and pericardial area, for all three experiments we  quantiﬁed
he magnitude of protoporphyrin accumulation using ﬂuorescence
icroscopy, as protoporphyrin autoﬂuoresces between 600 and
60 nm [1,15] and can be detected in situ within zebraﬁsh PPOX
utants [5].
. Materials and methods
.1. Animals
For all assays described below, we relied on a robust line of
ransgenic zebraﬁsh (ﬂi1:egfp) that stably express enhanced green
uorescent protein within vascular endothelial cells [12]. Although
e did not assess the potential impacts of butafenacil exposure on
ngiogenesis within this study, we relied on ﬂi1:egfp zebraﬁsh to
nalyze body length, pericardial area, and arterial circulation using
reviously optimized protocols [18], as well as protoporphyrin
ccumulation using procedures described below. Adult ﬂi1:egfp
ebraﬁsh were maintained on a 14-h:10-h light:dark cycle withinorts 2 (2015) 976–983 977
a ﬁve-shelf stand-alone system (Aquatic Habitats, Inc., Apopka, FL,
USA) containing photoperiod light-cycle enclosures and recircu-
lating conditioned reverse osmosis (RO) water. Dissolved oxygen,
pH, conductivity, salinity, alkalinity, and temperature within recir-
culating water were maintained at 4-6 mg/L, 6.5–7.5, 425–475 S,
<1 ppt, 50–100 mg/L, and 27–28 ◦C, respectively; in addition, lev-
els of ammonia, nitrite, and nitrate within recirculating water
were consistently below 0.1 mg/L, 0.05 mg/L, and 2 mg/L, respec-
tively. Adult females and males were bred directly on-system
using in-tank breeding traps suspended within 3-L tanks. For all
experiments described below, newly fertilized eggs were staged
according to previously described methods [10]. All ﬁsh were han-
dled and treated in accordance with approved Institutional Animal
Care and Use Committee protocols at the University of South Car-
olina – Columbia.
2.2. Chemicals
Butafenacil (99.3% purity) was purchased from Sigma–Aldrich
(St. Louis, MO). Stock solutions of each chemical were prepared by
dissolving chemicals in high performance liquid chromatography-
grade dimethyl sulfoxide (DMSO) (50 mM),  and then performing
two-fold serial dilutions into DMSO to create stock solutions
for each working solution. All stock solutions were stored at
room temperature within 2-mL amber glass vials containing
polytetraﬂuoroethylene-lined caps. For each exposure, working
solutions of all treatments were freshly prepared by spiking stock
solutions into embryo media (EM) (5 mM NaCl, 0.17 mM KCl,
0.33 mM CaCl2, 0.33 mM MgSO4), resulting in 0.1% DMSO within
all vehicle control and treatment groups.
2.3. Embryonic exposures
Newly fertilized eggs were collected immediately after spawn-
ing and placed in groups of approximately 100 per petri dish within
a light- and temperature-controlled incubator until 5 hpf. Prior to
each experiment, 50-mL glass beakers were thoroughly rinsed with
DMSO and RO water. For exposures in the presence of light, viable
ﬂi1:egfp embryos were exposed to vehicle (0.1% DMSO) or butafe-
nacil (0.025–0.78 M)  in triplicate glass beakers (20 per replicate
beaker) under a 14-h:10-h light:dark cycle and static conditions
at 28 ◦C from 5 to 72 hpf. For exposures in the absence of light,
embryos were exposed using identical treatment groups and exper-
imental conditions as above, except embryos were reared in the
dark from 5 to 72 hpf.
To identify developmental windows susceptible to butafenacil
exposure within the ﬁrst 72 h of zebraﬁsh embryogenesis, ﬂi1:egfp
embryos were exposed to vehicle (0.1% DMSO) or 0.09 M butafe-
nacil in triplicate glass beakers (20 per replicate beaker) using the
following static exposure scenarios: [1] 5–72 hpf; [2] 10–72 hpf; [3]
24–72 hpf; and [4] 48–72 hpf. All exposures were conducted under
a 14-h:10-h light:dark cycle and static conditions at 28 ◦C.
To determine whether butafenacil-induced effects were
reversible, ﬂi1:egfp embryos were ﬁrst placed in triplicate glass
beakers (20 per replicate beaker) and exposed to vehicle (0.1%
DMSO) or 0.09 M butafenacil from [1] 5–72 hpf, [2] 24–48 hpf, or
[3] 48–72 hpf. For the 24–48-hpf exposure scenario, embryos were
rinsed three times with clean EM,  and maintained in clean glass
beakers containing fresh EM until 72 hpf. All exposures were con-
ducted under a 14-h:10-h light:dark cycle and static conditions at
28 ◦C.2.4. Imaging procedures
At 72 hpf, hatched embryos were anesthetized with 100 mg/L
MS-222 and up to 16 surviving embryos were individually loaded
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Fig. 1. Butafenacil exposure from 5 to 72 hpf under normal light conditions results in decreased circulation, increased pericardial area, and increased protoporphyrin
accumulation. (A) Mean body length (±standard deviation), (B) mean pericardial area (±standard deviation), (C) mean circulation (±standard deviation), and (D) mean
protoporphyrin accumulation (±standard deviation) following exposure to vehicle (0.1% DMSO) or 0.025–0.78 M butafenacil. Numbers above each bar denote the number
of  embryos analyzed across three replicate beakers per treatment and 20 initial embryos per replicate beaker. Asterisk (*) denotes signiﬁcant difference from vehicle controls
(p  < 0.05). (E) Representative images of protoporphyrin accumulation within a 72-hpf embryo exposed to vehicle (left) or 0.09 M butafenacil (right) under light conditions;
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nto wells of a black 384-well glass-bottom microplate (Matri-
al Bioscience, Spokane, WA). The plate was then centrifuged at
00 rpm for 8 min  to help orient hatched embryos into right or
eft lateral recumbency on the bottom of the well. Using auto-
ated image acquisition procedures within our ImageXpress Microits within the yolk sac (white arrow). (For interpretation of the references to color
Wideﬁeld High-Content Screening System (Molecular Devices,
Sunnyvale, CA), each embryo was imaged to analyze the follow-
ing endpoints: body length, arterial circulation, pericardial area,
and protoporphyrin accumulation. Previously optimized proto-
cols and parameters were used to quantify body length, arterial
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Fig. 2. Butafenacil exposure from 5 to 72 hpf in the dark resulted in decreased circulation in the absence of effects on survival, pericardial area, and protoporphyrin
accumulation. (A) Mean body length (±standard deviation), (B) mean pericardial area (±standard deviation), (C) mean circulation (±standard deviation), and (D) mean
protoporphyrin accumulation (±standard deviation) following exposure to vehicle (0.1% DMSO) or 0.025–0.78 M butafenacil. Numbers above each bar denote the number
of  embryos analyzed across three replicate beakers per treatment and 20 initial embryos per replicate beaker. Asterisk (*) denotes signiﬁcant difference from vehicle controls
( pf em
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up  < 0.05). (E) Representative images of protoporphyrin accumulation within a 72-h
range  color represents autoﬂuorescence above a threshold of 115 relative ﬂuoresc
n  this ﬁgure legend, the reader is referred to the web version of this article.)
irculation, and pericardial area [18]. Using a tetramethylrho-
amine (TRITC) ﬁlter and 2X objective, one image per well
as acquired to detect autoﬂuorescence of accumulated proto-
orphyrin; these data were then analyzed by quantifying the
hreshold area within a range of 115–4000 relative ﬂuorescent
nits.bryo exposed to vehicle (left) or 0.09 M butafenacil (right) under dark conditions;
its within the yolk sac (white arrow). (For interpretation of the references to color
2.5. Statistical analysesAll statistical procedures were performed using SPSS Statistics
22.0 (Chicago, IL). A general linear model (GLM) analysis of vari-
ance (ANOVA) ( = 0.05) was  used for all data, as these data did
not meet the equal variance assumption for non-GLM ANOVAs.
980 J.K. Leet et al. / Toxicology Reports 2 (2015) 976–983
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eig. 3. Experimental design for identifying sensitive developmental windows of bu
air-wise Tukey-based multiple comparisons of least-squares
eans were performed to identify signiﬁcant differences among
reatment groups.
. Results
.1. Butafenacil-induced anemia occurs in the presence or
bsence of light
In the absence of effects on survival (97 ± 6%), body length
Fig. 1A), or pericardial area (Fig. 1B), static exposure of 5-hpf
ebraﬁsh embryos to 0.09 M butafenacil in glass beakers resulted
n a signiﬁcant decrease in arterial circulation at 72 hpf. This nom-
nal concentration was approximately ∼4-fold lower than the
oncentration required to signiﬁcantly decrease circulation (in the
bsence of teratogenic effects) within 384-well glass-bottom plates
13], a difference that was likely due to higher sorption of butafe-
acil to plastic well walls relative to glass beakers. In addition, we
etected a signiﬁcant increase in protoporphyrin accumulation fol-
owing exposure to 0.05 M butafenacil (Fig. 1D and E), suggesting
hat protoporphyrin accumulation was a more sensitive endpoint
elative to circulation.
.2. Butafenacil-induced protoporphyrin accumulation only
ccurs in the presence of light
Similar to exposures under a 14-h:10-h light:dark cycle,
xposure to butafenacil in the dark resulted in a concentration-
ependent decrease in circulation in the absence of effects on
urvival (>80%), body length (Fig. 2A), and pericardial area (Fig. 2B),
ith a signiﬁcant decrease in circulation starting at 0.05 M butafe-
acil (Fig. 2C). However, unlike embryos exposed under light
onditions, protoporphyrin accumulation was absent in embryos
xposed to 0.025–0.39 M (Fig. 2D and E) and, although signiﬁcant
rotoporphyrin accumulation was present following exposure to
.78 M butafenacil, this effect was orders of magnitude lower than
mbryos exposed to butafenacil under light conditions.cil exposure as well as the potential for recovery following transfer to clean water.
3.3. Embryonic zebraﬁsh are not susceptible to butafenacil
exposure following completion of pharyngula
To identify developmental stages susceptible to butafenacil-
induced anemia within the ﬁrst 72 h of zebraﬁsh embryogenesis,
we initiated exposure of embryos to vehicle or 0.09 M butafe-
nacil at 5, 10, 24, and 48 hpf (Fig. 3), and then analyzed body
length, pericardial area, circulation, and protoporphyrin accumula-
tion at 72 hpf. No signiﬁcant effects on body length were detected
across all treatment groups (Fig. 4A), and a signiﬁcant increase in
pericardial area was detected within exposures starting at 10 and
24 hpf (Fig. 4B). While a signiﬁcant decrease in circulation was only
observed when exposures were initiated at 5 and 10 hpf (Fig. 4C), a
signiﬁcant increase in protoporphyrin accumulation was  observed
when exposures were initiated at 5, 10, and 24 hpf (Fig. 4D).
3.4. Zebraﬁsh embryos require >24 h to eliminate and recover
from protoporphyrin accumulation following exposure to
butafenacil during pharyngula
To determine whether butafenacil-induced effects on circula-
tion and protoporphyrin accumulation were reversible, embryos
were then exposed to butafenacil from 24 to 48 hpf or 48–72 hpf;
as a positive control, embryos were also exposed to butafenacil
from 5 to 72 hpf (Fig. 3). No signiﬁcant effects on body length
were detected within any of the treatment groups (Fig. 5A), and
pericardial area was  only increased following a 24–48-hpf expo-
sure (Fig. 5B). As expected, exposure from 5 to 72 hpf resulted in a
signiﬁcant decrease in circulation and a signiﬁcant increase in pro-
toporphyrin accumulation (Fig. 5C and D). While no other exposure
scenario resulted in a signiﬁcant decrease in circulation, exposure
from 24 to 48 hpf resulted in a signiﬁcant increase in protopor-
phyrin accumulation relative to vehicle controls (Fig. 5D).4. Discussion
Using zebraﬁsh as a model, this study demonstrated that, while
butafenacil-induced anemia occurred in the presence or absence
J.K. Leet et al. / Toxicology Reports 2 (2015) 976–983 981
Fig. 4. Zebraﬁsh embryos are not susceptible to butafenacil exposure following completion of pharyngula (24–48 hpf). (A) Mean body length (±standard deviation), (B) mean
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iericardial area (±standard deviation), (C) mean circulation (±standard deviation), 
ehicle  (0.1% DMSO) or 0.09 M butafenacil from 5 to 72, 10 to 72, 24 to 72, or 48 t
eplicate beakers per treatment and 20 initial embryos per replicate beaker. Asteris
f light, butafenacil-induced protoporphyrin accumulation only
ccurred in the presence of light. Based on the known mode
f action of PPOX-inhibiting herbicides in various organisms [9],
utafenacil exposure of zebraﬁsh embryos in the presence of light
ay  have resulted in cellular accumulation and photooxidation of
rotoporphyrinogen to protoporphyrin. Moreover, direct interac-
ion of light with protoporphyrin precursors may  have resulted
n increased acute toxicity under light conditions. Protoporphyrin
an lead to reactive singlet oxygen formation in the presence of
ight, and photodermatitis within variegate porphyria patients is
hought to be caused by photooxidation of protoporphyrinogen
nd increased production of reactive oxygen species within skin
broblasts [2]. Similarly, as embryonic zebraﬁsh are transparent
ithin the ﬁrst few days of development, proliferating and differ-
ntiating cells throughout the embryo are exposed to light and may
e highly susceptible to oxidative stress caused by accumulated
rotoporphyrin.
During zebraﬁsh embryogenesis, red blood cell development (or
rythropoiesis) commences at early-segmentation (∼11 hpf) with
he migration of erythroid precursors toward the trunk midline
4]. Following migration, erythroid precursors undergo extensive
roliferation until early-pharyngula (∼25–26 hpf) to form approx-
mately 300 proerythroblasts [4]. Following intravasation into
eveloping blood vessels, proerythroblasts begin readily express-
ng genes required for red blood cell development (such as heme) mean protoporphyrin accumulation (±standard deviation) following exposure to
pf. Numbers above each bar denote the number of embryos analyzed across three
enotes signiﬁcant difference from vehicle controls (p < 0.05).
biosynthesis genes) and, by ∼30–36 hpf, rapidly mature into ery-
throcytes that remain in circulation until a second deﬁnitive wave
of erythropoiesis begins at 120 hpf [6,8]. While we  did not conﬁrm
butafenacil uptake following initiation of exposures at differ-
ent developmental stages, our data suggest that 72-hpf zebraﬁsh
embryos are not susceptible to butafenacil exposure following
completion of pharyngula (24–48 hpf), as [1] initiation of expo-
sure at 10 and 24 hpf resulted in a similar magnitude of effect
on pericardial area and protoporphryin accumulation and [2] ini-
tiation of exposure at 48 hpf resulted in no effect on circulation,
protoporphryin accumulation, or pericardial area. Although the
exposure duration was  shorter relative to initiation of exposure
at 5 hpf, increased pericardial area and protoporphryin accumu-
lation following exposure from 10 to 72 hpf or 24–72 hpf may
be due to higher initial doses of butafenacil during the migra-
tion, proliferation, and/or maturation of erythroid precursors from
early-segmentation (∼11 hpf) to mid-pharyngula (∼30–36 hpf).
Interestingly, protoporphyrin accumulation was  primarily
localized to the yolk sac of 72-hpf embryos, and embryos exposed
to butafenacil during pharyngula (24–48 hpf) failed to eliminate
protoporphyrin after a 24-h recovery period in clean EM.  These
ﬁndings suggest that either [1] butafenacil persisted within the
embryo following transfer to clean water and/or [2] protoporphyrin
was highly lipophilic and moderately persistent within zebraﬁsh
embryos. Nevertheless, as the yolk sac is transparent and large
982 J.K. Leet et al. / Toxicology Reports 2 (2015) 976–983
Fig. 5. Embryos require >24 h to eliminate and recover from protoporphyrin accumulation following exposure to butafenacil during pharyngula (24–48 hpf). (A) Mean
body  length (±standard deviation), (B) mean pericardial area (±standard deviation), (C) mean circulation (±standard deviation), (D) mean protoporphyrin accumulation
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t±standard deviation) following exposure to vehicle (0.1% DMSO) or 0.09 M butaf
f  embryos analyzed across three replicate beakers per treatment and 20 initial emb
p  < 0.05).
relative to the total body area) within 72-hpf embryos, the yolk
ac is also susceptible to light exposure and, as such, a probable
ource of oxidative stress in the presence of protopophyrin accumu-
ation. Therefore, future research is needed to determine whether
eactive oxygen species are generated within the protoporphyrin-
ontaining yolk sac of butafenacil- and light-exposed embryos.
In summary, this study resulted in four major ﬁndings: (1)
utafenacil-induced anemia occurs in the presence or absence
f light; (2) butafenacil-induced protoporphyrin accumulation
nly occurs in the presence of light; (3) embryonic zebraﬁsh are
ot susceptible to butafenacil exposure following completion of
haryngula; and (4) zebraﬁsh embryos require >24 h to eliminate
nd recover from protoporphyrin accumulation following exposure
o butafenacil during pharyngula. While our ﬁndings suggest that
utafenacil inhibits PPOX during erythropoiesis, future research is
eeded to conﬁrm that butafenacil is a potent inhibitor of recombi-
ant zebraﬁsh PPOX and butafenacil impacts red blood cells alone
and not other blood cells such as macrophages, neutrophils, etc.).
n addition to identifying potential adverse hematologic effects
uring drug development, it is also important to ensure that drugs
o not exacerbate conditions of diseases such as anemia and
ariegate porphyria. Therefore, the ability to identify anemia- or
ariegate porphyria-inducing side effects would be a valuable addi-
ion to screening used for drug discovery or development, as well from 5 to 72, 24 to 48, or 48 to 72 hpf. Numbers above each bar denote the number
er replicate beaker. Asterisk (*) denotes signiﬁcant difference from vehicle controls
as other chemical screening applications. While certain zebraﬁsh
mutant strains with disrupted blood cell development or differen-
tiation are available [5,16], these strains have mainly been used to
investigate the molecular mechanisms of hematopoiesis and may
not be a viable option for pre-clinical screening applications. In
addition to low fecundity, these mutant zebraﬁsh strains usually do
not live beyond 2–3 weeks, requiring maintenance as a heterozy-
gous strain [5,16]. Therefore, the use of wildtype or homozygous
transgenic reporter zebraﬁsh lines (such as ﬂi1:egfp) and butafe-
nacil as a positive control has potential utility in drug discovery
and development, as both anemia and variegate porphyria can be
easily induced by butafenacil and rapidly identiﬁed within an intact
organism.
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